Brenthurst Wealth Management (PTY) LTD FSP No. 7833

MAY 2020 • ISSUE 347

Page 1 May 2020 - Issue 347

THE POWER OF INDEPENDENT ADVICE

JHB ( HQ) +27 (0) 11 799 8100

JHB (SANDTON) +27 (0) 10 035 1391

PTA +27 (0) 12 347 8240

CAPE TOWN +27 (0) 21 418 1236

BELLVILLE +27 (0) 21 914 9646

CLAREMONT +27 (0) 21 418 1236

STELLENBOSCH +27 (0) 21 882 8706

MAURITIUS + 230 5843 5215

FOR MORE INFO CONTACT US

BRENTHURST HAS LIMITED

ACCESSIBILITY FOR INVESTMENT

INTO THE SYGNIA OSI FUND VIA

RETIREMENT ANNUITIES,

PRESERVATION FUNDS, LIVING

ANNUITIES AND

ENDOWMENT STRUCTURES.

By Brian Butchart, Managing Director and CFP, Brenthurst Wealth Management

Social and environmental change is happening faster than ever imagined,

including climate change, shifting demographics and technology disrup-

tion that is reshaping the world we live in.

Companies that can adapt faster to the change will thrive in such an envi-

ronment and be more successful in attracting customers, employees and

growing their businesses. The world of investments is no different.

There is an increased demand from Millennials, high net-worth individual

investors and regulators seeking investment opportunities and capital

deployment with a meaningful social and environmental impact.

Investors want returns, but they also want their investments to provide

better outcomes for society and the environment.

Social factors include rising global inequality-the need for affordable access

to healthcare, education, inclusive financing and housing. Environmental

factors such as climate change is a major threat to humanity and is driving

the need for renewable and efficient energy and sustainable agriculture

and forestry.

The advancement of technology is providing solutions to these social and

environmental issues at a faster pace and lower cost, with the objective of

having a meaningful impact and the potential to deliver exceptional long-

term returns to investors. This is referred to as impact investing.

INVESTMENT IN THE SYGNIA OXFORD SCIENCES INNOVATION FUND IS A

LIMITED AND ONCE IN A LIFETIME OPPORTUNITY!

“Investing in the future of humankind”

SYGNIA OXFORD SCIENCES INNOVATION FUND

Brenthurst Wealth Management (PTY) LTD FSP No. 7833 Page 2 May 2020 - Issue 347

Direct impact investing is, however, not accessible via traditional asset classes, but there are no short-

age of opportunities, likely to deliver exceptional returns. One such investment opportunity is the

SYGNIA OXFORD SCIENCES INNOVATION (OSI) FUND.

The University of Oxford, was rated the number one research university in the world for a third year in a

row in 2019, endorsing the quality of science ingenuity at Oxford.

OSI’s investment principals work with academics to create spin-out businesses from their patents.

They help to build the management team and develop the product through to revenue generation.

The OSI fund will give investors exposure to at least 80 spin-out companies in the fields of technology and

biosciences including genomics, artificial intelligence, fintech and quantum computing to name a few.

In the four years since OSI was established its market capitalization has risen to GBP738 million pounds

Sterling as at 31 December 2019, with over GBP390 million pounds Sterling available in cash for future

investments.

This is a rand denominated offshore fund exposed to general market risk, exchange rate risk, liquidity

risk and legal and regulatory risks, but likely to grow exponentially. The investable businesses and ideas

are based on years of rigorous scientific research and supported by significant research and develop-

ment by the Oxford University, and are tested and validated by professional researchers and academics,

subject to peer review and overseen by global business leaders and investors acting as funders an d

advisors.

The SYGNIA OXFORD SCIENCES INNOVATION FUND

invests in shares of Oxford Sciences Innovation Plc

– a platform company partnered with the University

of Oxford to convert its patents and research ideas

into commercial enterprises – and in select spin-out

companies that have achieved scale and success.

The Sygnia OSI fund invests in the shares of the Oxford Sciences innovation company partnered with

the University of Oxford to convert its patents and research ideas into commercial enterprises creating

select spin-out companies that are already in an advanced stage of growth and success. The OSI fund

provides accessibility to companies incubated at Oxford University, which through technology-driven

innovation is revolutionising healthcare and reducing the impact of climate change.

INV

ES

TM

EN

T O

PP

OR

TU

NIT

IES

Read more >>

Oxford-University-Covid-19-Vaccine

AstraZeneca and Oxford university agree deal to develop virus vaccine

Page 3 May 2020 - Issue 347

Brenthurst Wealth Management (PTY) LTD FSP No. 7833

SP

IN-O

UT

BU

SIN

ES

SE

S

SOME OF THESE EXCITING SPIN-OUT BUSINESSES INCLUDE:

EVOX THERAPEUTICS is harnessing the natural delivery capabilities in the human body to treat serious

diseases. Exosomes are nanosized vesicles secreted by all cells in the human body and is the natural

way cells deliver proteins and nucleic acids to other cells. Evox has developed technology using the

body’s Exosomes to deliver drugs in nanoparticles to specifically targeted organs in isolation such as

the Brain and central nervous system, reducing toxicity to other parts of the body.

OSLER have created portable hand-held devices to enable anyone to test for a majority of biomarkers

such as cholesterol, diabetes, proteins and auto-immune diseases immediately, accurately and cost

effectively without an expensive lab-based blood test and delayed results.

VACCITECH developed two viral vector vaccines, one to prevent influenza and the other to treat

prostate cancer. It is also in the race to produce a vaccine for COVID-19, which is already in human

testing trials.

Brenthurst has limited accessibility for investment

into the Sygnia OSI Fund via retirement annuities,

preservation funds, living annuities and endow-

ment structures.

MINIMUM INVESTMENT AMOUNT APPLIES.

For any further information on this limited and unique investment opportunity please contact any of our highly qualified financial planners or mail brian@brenthurstwealth.co.za

These individual businesses and others are exclusively accessible via investment in the OSI company

through the Sygnia OSI Fund. Investment in the fund is restricted to leading wealth management

businesses and capacity is limited.

Creates novel vaccines that elicit strong responses from T-cells

1

3

2

Brenthurst Wealth Management is an authorised financial services provider (Reg No: 2004/012998/07) FSP No.7833. This e-mail and any file attachments transmitted with it are intended solely for the addressee(s) and may be legally privileged and/or confidential. If you have received this e-mail in error please destroy it. If you are not the addressee you may not disclose, copy, distribute or take any action based on the contents hereof. Any

unauthorised use or disclosure is prohibited and may be unlawful. The view and opinions expressed in this e-mail message may not necessarily be those of the management of Brenthurst Wealth Management (Pty) Limited.

Page 4 May 2020 - Issue 347

PLEASE DO NOT HESITATE TO CONTACT ANY OF OUR HIGHLY QUALIFIED FINANCIAL ADVISORS AT OUR OFFICES COUNTRYWIDE. Brenthurst Investment-Strategist & Planners

Brenthurst Wealth Management (PTY) LTD FSP No. 7833

Portfolio managers with a proven and successful track record in building businesses and investing, supported by a highly experienced team of investment professionals

Ownership of University of Oxford’s IP, the “global superbrand” of intellectual and research capital in perpetuity

WHY SYGNIA [OSI] OXFORD SCIENCES INNOVATION FUND?

1

2

3

4

5

6

7

Access to an existing portfolio of OU’s “best-of-breed” investment opportunities (80) with a 5 year history (many companies are now valued at £20-50 million) and undeployed cash of £390 million

Performance uncorrelated to market performance Performance from 1 May 2019 to 31 March 2020: 23.1% vs 7.9% S&P500 Index Expected GBP revaluation in the next 6 months: 20%

Sustainable and direct impact investing in a risk-diversified manner

Brenthurst Wealth would like to invite you to a special webinar session, Wed, 6th May at 11:00. Listen to Magnus Heystek (Brenthurst) and Magda Wierzycka (Sygnia) presenting on how to survive and

thrive in the Coronavirus economy and Sygnia’s new OXFORD SCIENCES INNOVATION FUND

WEBINAR INVITATION Investing in the future of humankind

Date: Wednesday 06th May at 11h00 (The webinar will last approximately 1 hour) Platform: The webinar will be hosted on Zoom

https://us02web.zoom.us/webinar/register/WN_qlukTQInQtiAsPGDO-UulQ REGISTER HERE

Invest alongside the most prestigious names in global asset management

Right sector for the right times: Access to a pipeline of future deals in the sphere of biosciences/healthcare and technology-driven innovation

SOCIALLY

RESPONSIBLE

INVESTING

HAS NEVER

BEEN MORE

RELEVANT

After registering, you will receive a confirmation email containing information about joining the webinar.

MAGDA WIERZYCKA SYGNIA CEO

MAGNUS HEYSTEK INVESTMENT STRATEGIST

BRIAN BUTCHART MANAGING DIRECTOR

BRENTHURST

HAS LIMITED

ACCESS TO THE

SYGNIA OXFORD

SCIENCES

INNOVATION

FUND

The event is limited to 1000 guests